Economic Burden of Thalassemia Major in Iran 2015

摘要

Major Thalassemia is an autosomal recessive disease with complications,mortality and serious pathology. Today, the life expectancy of patients with major thalassemiahas increased along with therapeutic advances. Therefore, they need lifelong care, and caringfor them would incur many costs. Being aware of the patients’ costs can be effective forcontrolling and managing the costs and providing efficient treatments for the care of patients.Hence, this study was conducted to estimate the economic burden of the patients with majorthalassemia.